2Catherine MP, Michael AM, Jean- Louis F. Pancreatitis -associated acute lung injury : new insights [ J ]. Chest, 2003,124 ( 6 ) : 2341 - 2351.
3Ken - Ichiro lnoue, Hirohisa Takano, Akinori Shimada, et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide [J].Mol Pharmacol,2005,67 ( 3 ) : 673 - 680.
4Jia Sun,Madhav Bhatia. Blockade of neurokinin - 1 receptor attenuates CC and CXC chemokine production in experimental acute pancreatitis and associated lung injury[J]. Am J Physiol Gastrointest Liver Physiol, 2007,292 : G143 - G153.
5Van - Acker G J, Perides G, Weiss ER, et al. Tumor progression locus -2 is a critical regulator of pancreatic and lung inflammation (luring acute pancreatitis [ J ]. J Biol Chem, 2007,282 ( 30 ) : 22140 - 22149.
6Foitzik T,Eibl G,Hotz HG,et al. Endothelin receptor blockade in severe acute pancreatitis leads systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates [ J ]. Surgery,2000,128 ( 3 ) :399 - 407.
7Kawamura T, Inada K, Akasaka N,et al. Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery[J]. Can J Anaesth,1996,43(5 Pt1 ) : 456 -460.
8Ken - Ichiro Inoue, Hirohisa Takano, Rie Yanagisawa, et al. Protective role of urinary trypsininhibitor in acute lung injury induced by lipopolysaceharide [J]. Experimental Biology and Medicine, 2005,230 (4) :281 -287.
9Perenlei Molor-Erdene, Kenji Okajima, et al. Urinary trypsin inhibitor reduces LPS - induced hypotension by suppressing tumor necrosis factor - production through inhibition of Egr - 1 expression [J]. Am J Physiol Heart Circ Physiol, 2005, 288(3) : H1265 - H1271.
